A Multi-centre Observational Study of the Axium Neurostimulator as a Treatment for Chronic Pain

NCT02169401 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 135

Last updated 2024-11-14

Study results available
· View outcomes & findings →

Summary

08-SMI-2012 is a post market, observational, questionnaire based study to assess the effectiveness of the commercially available Axium neurostimulator in the management of intractable, chronic pain.

Conditions

Interventions

DEVICE

Implantation with the commercially available Axium Neurostimulator

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • S ElDabe, Prof · James Cook University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2017-01-25
Completion
2017-01-25

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02169401 on ClinicalTrials.gov